N

NKGen Biotech Inc
NASDAQ:NKGN

Watchlist Manager
NKGen Biotech Inc
NASDAQ:NKGN
Watchlist
Price: 0.06 USD Market Closed
Market Cap: $7.5m

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
$0
/
$0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Operating
Margin
US
NKGen Biotech Inc
NASDAQ:NKGN
7.5m USD
Loading...
IN
Aaswa Trading and Exports Ltd
BSE:512038
26.9T INR
Loading...
US
GE Vernova LLC
NYSE:GEV
193.6B USD
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
US
Schlumberger NV
NYSE:SLB
72B USD
Loading...
US
Baker Hughes Co
NASDAQ:BKR
55.2B USD
Loading...
IN
GTV Engineering Ltd
BSE:539479
4.5T INR
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
46.2B USD
Loading...
CH
Galderma Group AG
SIX:GALD
34.1B CHF
Loading...
US
Reddit Inc
NYSE:RDDT
34.2B USD
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

NKGen Biotech Inc
Glance View

Market Cap
7.5m USD
Industry
N/A

NKGen Biotech Inc is a US-based company operating in industry. The company is headquartered in Santa Ana, California. The company went IPO on 2021-05-21. NKGen Biotech, Inc. is a clinical-stage biotechnology company. The firm is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing its (SuperNK) SNK (super-activated) platform. SNK involves the infusion of one’s own activated NK cells into the body to improve immune system function, eliminate diseased or abnormal cells and prevent recurrence. SNK uses pure NK cells harvested from the patient’s blood, activated and infused back into the patient’s body. SNK has a therapeutic potential within the areas of cancer, autoimmune and neurodegenerative diseases. Autologous NK cell immunotherapy is a treatment that provides immune enhancement using pure NK cells harvested from a patient’s body. The company is also focused on conducting clinical trials with its super-activated NK cell therapy in patients with neurodegenerative disease (SNK01) and cancer (SNK02).

NKGN Intrinsic Value
Not Available
N
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top